BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saneja A, Khare V, Alam N, Dubey RD, Gupta PN. Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance. Expert Opinion on Drug Delivery 2013;11:121-38. [DOI: 10.1517/17425247.2014.865014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Michaelis M, Rothweiler F, Wurglics M, Aniceto N, Dittrich M, Zettl H, Wiese M, Wass M, Ghafourian T, Schubert-Zsilavecz M, Cinatl J. Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport. Oncotarget 2016;7:11664-76. [PMID: 26887049 DOI: 10.18632/oncotarget.7345] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 Haase K, Offeddu GS, Gillrie MR, Kamm RD. Endothelial Regulation of Drug Transport in a 3D Vascularized Tumor Model. Adv Funct Mater 2020;30:2002444. [PMID: 33692661 DOI: 10.1002/adfm.202002444] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 16.5] [Reference Citation Analysis]
3 Lawal B, Kuo YC, Sumitra MR, Wu ATH, Huang HS. In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. J Inflamm Res 2021;14:4901-13. [PMID: 34588796 DOI: 10.2147/JIR.S329401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Saneja A, Nayak D, Srinivas M, Kumar A, Khare V, Katoch A, Goswami A, Vishwakarma RA, Sawant SD, Gupta PN. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Eur J Pharm Sci. 2017;97:79-91. [PMID: 27989859 DOI: 10.1016/j.ejps.2016.10.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
5 Ngo TD, Tran TD, Le MT, Thai KM. Machine learning-, rule- and pharmacophore-based classification on the inhibition of P-glycoprotein and NorA. SAR QSAR Environ Res 2016;27:747-80. [PMID: 27667641 DOI: 10.1080/1062936X.2016.1233137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Aboulfotouh K, Allam AA, El-badry M, El-sayed AM. Self-emulsifying drug–delivery systems modulate P-glycoprotein activity: role of excipients and formulation aspects. Nanomedicine 2018;13:1813-34. [DOI: 10.2217/nnm-2017-0354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
7 Dubey RD, Saneja A, Qayum A, Singh A, Mahajan G, Chashoo G, Kumar A, Andotra SS, Singh SK, Singh G, Koul S, Mondhe DM, Gupta PN. PLGA nanoparticles augmented the anticancer potential of pentacyclic triterpenediol in vivo in mice. RSC Adv 2016;6:74586-97. [DOI: 10.1039/c6ra14929d] [Cited by in Crossref: 14] [Article Influence: 2.3] [Reference Citation Analysis]
8 Di Mizio G, Marcianò G, Palleria C, Muraca L, Rania V, Roberti R, Spaziano G, Piscopo A, Ciconte V, Di Nunno N, Esposito M, Viola P, Pisani D, De Sarro G, Raffi M, Piras A, Chiarella G, Gallelli L. Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications. Int J Environ Res Public Health 2021;18:12936. [PMID: 34948545 DOI: 10.3390/ijerph182412936] [Reference Citation Analysis]
9 Rana R, Rani S, Kumar V, Nakhate KT, Ajazuddin, Gupta U. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities. AAPS PharmSciTech 2021;23:10. [PMID: 34862568 DOI: 10.1208/s12249-021-02170-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zha G, Qin H, Youssif BG, Amjad MW, Raja MAG, Abdelazeem AH, Bukhari SNA. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance. European Journal of Medicinal Chemistry 2017;135:34-48. [DOI: 10.1016/j.ejmech.2017.04.025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
11 Syamala PS, Ramesan RM. Thiol redox-sensitive cationic polymers for dual delivery of drug and gene. Ther Deliv 2018;9:751-73. [PMID: 30277132 DOI: 10.4155/tde-2018-0041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, Mondhe DM, Panda AK, Gupta PN. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Int J Pharm 2017;531:153-66. [PMID: 28823888 DOI: 10.1016/j.ijpharm.2017.08.076] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
13 Saneja A, Arora D, Kumar R, Dubey RD, Panda AK, Gupta PN. Therapeutic applications of betulinic acid nanoformulations. Ann N Y Acad Sci 2018;1421:5-18. [PMID: 29377164 DOI: 10.1111/nyas.13570] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
14 Ashraf T, Kao A, Bendayan R. Functional Expression of Drug Transporters in Glial Cells. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders. Elsevier; 2014. pp. 45-111. [DOI: 10.1016/bs.apha.2014.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
15 Dubey RD, Saneja A, Gupta PK, Gupta PN. Recent advances in drug delivery strategies for improved therapeutic efficacy of gemcitabine. Eur J Pharm Sci 2016;93:147-62. [PMID: 27531553 DOI: 10.1016/j.ejps.2016.08.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
16 Han SY, Lu Q, Lee K, Choi YH. LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats. Pharmaceutics 2019;11:E135. [PMID: 30897775 DOI: 10.3390/pharmaceutics11030135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Arora D, Jaglan S. Nanocarriers based delivery of nutraceuticals for cancer prevention and treatment: A review of recent research developments. Trends in Food Science & Technology 2016;54:114-26. [DOI: 10.1016/j.tifs.2016.06.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
18 Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Acta Biomater 2015;14:115-24. [PMID: 25498306 DOI: 10.1016/j.actbio.2014.12.001] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 12.4] [Reference Citation Analysis]
19 Saneja A, Sharma L, Dubey RD, Mintoo MJ, Singh A, Kumar A, Sangwan PL, Tasaduq SA, Singh G, Mondhe DM, Gupta PN. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate. Mater Sci Eng C Mater Biol Appl 2017;73:616-26. [PMID: 28183653 DOI: 10.1016/j.msec.2016.12.109] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
20 Tan S, Zou C, Zhang W, Yin M, Gao X, Tang Q. Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv 2017;24:1831-42. [PMID: 29182031 DOI: 10.1080/10717544.2017.1406561] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
21 Diallinas G. Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters. Front Pharmacol 2014;5:207. [PMID: 25309439 DOI: 10.3389/fphar.2014.00207] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
22 Liang L, Qiu L. Vitamin E succinate with multiple functions: A versatile agent in nanomedicine-based cancer therapy and its delivery strategies. Int J Pharm 2021;600:120457. [PMID: 33676991 DOI: 10.1016/j.ijpharm.2021.120457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Gala UH, Miller DA, Williams RO 3rd. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochim Biophys Acta Rev Cancer 2020;1873:188319. [PMID: 31678141 DOI: 10.1016/j.bbcan.2019.188319] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
24 Sprachman MM, Laughney AM, Kohler RH, Weissleder R. In vivo imaging of multidrug resistance using a third generation MDR1 inhibitor. Bioconjug Chem 2014;25:1137-42. [PMID: 24806886 DOI: 10.1021/bc500154c] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
25 Zhong P, Zhang J, Deng C, Cheng R, Meng F, Zhong Z. Glutathione-Sensitive Hyaluronic Acid-SS-Mertansine Prodrug with a High Drug Content: Facile Synthesis and Targeted Breast Tumor Therapy. Biomacromolecules 2016;17:3602-8. [DOI: 10.1021/acs.biomac.6b01094] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
26 Arora D, Jaglan S. Therapeutic applications of resveratrol nanoformulations. Environ Chem Lett 2018;16:35-41. [DOI: 10.1007/s10311-017-0660-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
27 Saneja A, Kumar R, Mintoo MJ, Dubey RD, Sangwan PL, Mondhe DM, Panda AK, Gupta PN. Gemcitabine and betulinic acid co-encapsulated PLGA-PEG polymer nanoparticles for improved efficacy of cancer chemotherapy. Mater Sci Eng C Mater Biol Appl 2019;98:764-71. [PMID: 30813082 DOI: 10.1016/j.msec.2019.01.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
28 Chang KL, Pee HN, Yang S, Ho PC. Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease. Sci Rep 2015;5:9000. [PMID: 25760794 DOI: 10.1038/srep09000] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
29 Saneja A, Alam N, Dubey R, Gupta P. Recent Advances in Self-Emulsifying Drug-Delivery Systems for Oral Delivery of Cancer Chemotherapeutics. Nanoarchitectonics for Smart Delivery and Drug Targeting. Elsevier; 2016. pp. 379-404. [DOI: 10.1016/b978-0-323-47347-7.00014-8] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 Todoroki H, Iwatsu M, Urabe D, Inoue M. Total Synthesis of (−)-4-Hydroxyzinowol. J Org Chem 2014;79:8835-49. [DOI: 10.1021/jo501666x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
31 Noppawan S, Mongkolthanaruk W, Suwannasai N, Senawong T, Moontragoon P, Boonmak J, Youngme S, McCloskey S. Chemical constituents and cytotoxic activity from the wood-decaying fungus Xylaria sp. SWUF08-37. Nat Prod Res 2020;34:464-73. [PMID: 30257108 DOI: 10.1080/14786419.2018.1488709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Arora D, Kumar A, Gupta P, Chashoo G, Jaglan S. Preparation, characterization and cytotoxic evaluation of bovine serum albumin nanoparticles encapsulating 5-methylmellein: A secondary metabolite isolated from Xylaria psidii. Bioorg Med Chem Lett 2017;27:5126-30. [PMID: 29100800 DOI: 10.1016/j.bmcl.2017.10.064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
33 Ngo TD, Tran TD, Le MT, Thai KM. Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds. Mol Divers 2016;20:945-61. [PMID: 27431577 DOI: 10.1007/s11030-016-9688-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
34 Dallavalle S, Dobričić V, Lazzarato L, Gazzano E, Machuqueiro M, Pajeva I, Tsakovska I, Zidar N, Fruttero R. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resist Updat 2020;50:100682. [PMID: 32087558 DOI: 10.1016/j.drup.2020.100682] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
35 Han SY, Kim ES, You BH, Chae HS, Lu Q, Chin YW, Ahn HC, Chung SJ, Lee K, Choi YH. Effect of treatment period with LC478, a disubstituted adamantayl derivative, on P-glycoprotein inhibition: its application to increase docetaxel absorption in rats. Xenobiotica 2020;50:863-74. [PMID: 31791185 DOI: 10.1080/00498254.2019.1700318] [Reference Citation Analysis]
36 Ren Q, Zhao S, Zhu Y, Mao J, Liu X, Ye J, Zhang Q, Xu X. Supramolecular aggregates of myricetin improve its bioavailability and its role in counteracting alcoholism. Journal of Drug Delivery Science and Technology 2022;74:103515. [DOI: 10.1016/j.jddst.2022.103515] [Reference Citation Analysis]
37 Dhritlahre RK, Ruchika, Padwad Y, Saneja A. Self-emulsifying formulations to augment therapeutic efficacy of nutraceuticals: From concepts to clinic. Trends in Food Science & Technology 2021;115:347-65. [DOI: 10.1016/j.tifs.2021.06.046] [Reference Citation Analysis]
38 Teng YN, Hsieh YW, Hung CC, Lin HY. Demethoxycurcumin modulates human P-glycoprotein function via uncompetitive inhibition of ATPase hydrolysis activity. J Agric Food Chem 2015;63:847-55. [PMID: 25594233 DOI: 10.1021/jf5042307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
39 Le M, Trinh DT, Ngo T, Tran-nguyen V, Nguyen D, Hoang T, Nguyen H, Do T, Mai TT, Tran T, Thai K, Tsai F. Chalcone Derivatives as Potential Inhibitors of P-Glycoprotein and NorA: An In Silico and In Vitro Study. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/9982453] [Reference Citation Analysis]
40 Anderson LL, Etchart MG, Bahceci D, Golembiewski TA, Arnold JC. Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations. Sci Rep 2021;11:14948. [PMID: 34294753 DOI: 10.1038/s41598-021-94212-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zhang J, Wang L, Fai Chan H, Xie W, Chen S, He C, Wang Y, Chen M. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells. Sci Rep 2017;7:46057. [PMID: 28470171 DOI: 10.1038/srep46057] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
42 Jing W, Zhang X, Zhou H, Wang Y, Yang M, Long L, Gao H. Naturally occurring cassane diterpenoids (CAs) of Caesalpinia: A systematic review of its biosynthesis, chemistry and pharmacology. Fitoterapia 2019;134:226-49. [DOI: 10.1016/j.fitote.2019.02.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
43 Thai KM, Huynh NT, Ngo TD, Mai TT, Nguyen TH, Tran TD. Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks. SAR QSAR Environ Res 2015;26:139-63. [PMID: 25588022 DOI: 10.1080/1062936X.2014.995701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Saneja A, Nehate C, Alam N, Gupta PN. Recent Advances in Chitosan-Based Nanomedicines for Cancer Chemotherapy. In: Dutta PK, editor. Chitin and Chitosan for Regenerative Medicine. New Delhi: Springer India; 2016. pp. 229-59. [DOI: 10.1007/978-81-322-2511-9_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
45 Jain AK, Jain S. Advances in oral delivery of anti-cancer prodrugs. Expert Opin Drug Deliv 2016;13:1759-75. [PMID: 27292717 DOI: 10.1080/17425247.2016.1200554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
46 Jansson PJ, Yamagishi T, Arvind A, Seebacher N, Gutierrez E, Stacy A, Maleki S, Sharp D, Sahni S, Richardson DR. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp). J Biol Chem 2015;290:9588-603. [PMID: 25720491 DOI: 10.1074/jbc.M114.631283] [Cited by in Crossref: 79] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
47 Arora D, Jaglan S. Nanocarriers for Resveratrol Delivery. In: Ranjan S, Dasgupta N, Lichtfouse E, editors. Nanoscience in Food and Agriculture 5. Cham: Springer International Publishing; 2017. pp. 123-38. [DOI: 10.1007/978-3-319-58496-6_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
48 Szwed M, Kania KD, Jozwiak Z. Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin. Cell Oncol (Dordr) 2014;37:421-8. [PMID: 25410120 DOI: 10.1007/s13402-014-0205-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]